About
About Zhejiang CONBA Pharmaceutical Co.,Ltd
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In addition, it offers prescription pieces, formula granules, plant extracts, and other products. The company offers its products under Aokang, Jindi, Jinaikang, Qianliekang, Tianbaoning, Jinkang Su, Li, Zhixinyan, Kang Enbei, Baozhilin, and Yangyingtang brands. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1969 and is headquartered in Hangzhou, China.
Visit company website
5 years, 5 months ago
Zhejiang CONBA Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 5.3% below its 200 day moving average.
From a valuation standpoint, the stock is 80.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
Zhejiang CONBA Pharmaceutical Co.,Ltd's total revenue sank by 22.7% to $1B since the same quarter in the previous year.
Its net income has dropped by 28.7% to $60M since the same quarter in the previous year.
Finally, its free cash flow fell by 95.3% to $13M since the same quarter in the previous year.
Based on the above factors, Zhejiang CONBA Pharmaceutical Co.,Ltd gets an overall score of 1/5.